COST PLUS FIXED FEE

IIT RESEARCH INSTITUTE - FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

PIID: 75N95024F00002Solicitation ID: 75N95024R00117

Signed Date: Nov 21, 2025Effective Date: Sep 18, 2024End Date: Closed on Dec 31, 2025

Award $

$512K

Vendor

IIT RESEARCH INSTITUTE

NAICS

541715

Signed Date

Nov 21, 2025

Key Details

Dollars Obligated

$512,266

Base & All Options

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

CHICAGO, IL, 606163717, CD-IL-01

FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS

On Nov 21, 2025, Department of Health and Human Services obligated $512,266 to IIT RESEARCH INSTITUTE for first-in-class small molecule candidate ncgc72 (cd206 agonist) for immunologically cold solid organ cancers. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 4 offers received. Performance is located in CHICAGO, IL.